Clinical Trial Update: An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This Phase 2 multicenter trial evaluated the usability and safety of the SB4 autoinjector and pre-filled syringe in patients with rheumatoid arthritis; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SB4 (etanercept biosimilar)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED